Even stronger obesity drug could further change weight-loss care
FDA approval for use of tirzepatide for chronic weight management could come this year, drugmaker Eli Lilly said.
FDA approval for use of tirzepatide for chronic weight management could come this year, drugmaker Eli Lilly said.